STAT5 signaling is associated with the outcome of follicular and mantle cell lymphoma patients treated with immunochemotherapy.

被引：0

作者：

Leppae, Sirpa ^{[1
,2
]}

Taskinen, Minna ^{[2
]}

Sommarhem, Antti ^{[1
,3
]}

Elonen, Erkki ^{[4
]}

Nykter, Matti ^{[5
]}

Monni, Outi ^{[6
,7
]}

Timonen, Tuomo

Hautaniemi, Sampsa ^{[7
]}

Karjalainen-Lindsberg, Marja-Liisa ^{[8
]}

Meri, Seppo ^{[3
]}

机构：

[1] Univ Helsinki, Cent Hosp, Dept Oncol, Helsinki, Finland

[2] Univ Helsinki, Mol Canc Biol Program, Helsinki, Finland

[3] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland

[4] Univ Helsinki, Haartman Inst, Dept Hematol, Helsinki, Finland

[5] Tampere Univ Technol, Inst Signal Proc, FIN-33101 Tampere, Finland

[6] Univ Helsinki, Biomedicum Biochip Ctr, FIN-00014 Helsinki, Finland

[7] Univ Helsinki, Inst Biomed & Genome, Scale Biol Res Program, FIN-00014 Helsinki, Finland

[8] Univ Helsinki, Haartman Inst, Dept Pathol, FIN-00014 Helsinki, Finland

来源：

BLOOD | 2007年 / 110卷 / 11期

关键词：

D O I：

10.1182/blood.V110.11.2626.2626

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2626

引用

页码：773A / 773A

页数：1

共 50 条

[1] Prognostic Impact of Microvessel Density in Follicular Lymphoma Patients Treated with Immunochemotherapy.
Taskinen, Minna
Bono, Petri
Leppa, Sirpa
BLOOD, 2008, 112 (11) : 980 - 980
[2] INITIAL TREATMENT RESPONSE PREDICTS THE OUTCOME OF ELDERLY FOLLICULAR LYMPHOMA PATIENTS TREATED WITH IMMUNOCHEMOTHERAPY
Andjelic, B.
Jelicic, J.
Todorovic, M.
Bila, J.
Antic, D.
Djurasinovic, V.
Sretenovic, A.
Vukovic, V.
Smiljanic, M.
Mihaljevic, B.
HAEMATOLOGICA, 2016, 101 : 757 - 757
[3] FCGRIIIA Polymorphisms are not associated with outcome in follicular or mantle-cell lymphoma patients treated,with HDT/SCT and Rituximab.
Pennell, N
Buckstein, R
Spaner, D
Imrie, K
Mangel, J
Boudreau, A
Berinstein, NL
BLOOD, 2002, 100 (11) : 479B - 479B
[4] Rituximab maintenance for 2 years in patients with untreated high tumor burden follicular lymphoma after response to immunochemotherapy.
Salles, G. A.
Seymour, J. F.
Feugier, P.
Offner, F.
Lopez-Guillermo, A.
Bouabdallah, R.
Pedersen, L. M.
Brice, P.
Belada, D.
Xerri, L.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[5] T CELL RESPONSES STAT5 reins in the follicular helpers
Bordon, Yvonne
NATURE REVIEWS IMMUNOLOGY, 2012, 12 (03) : 152 - 152
[6] An organ-preserving strategy in patients with esophageal squamous cell carcinoma treated with immunochemotherapy.
Guo, Yijia
Kou, Xiaoge
Zhuang, Wu
Ye, Huangyang
Yang, Mudan
Liu, Yunpeng
Yu, Guohua
Qi, Xiao
Wang, Qingyu
Huang, Jing
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 424 - 424
[7] DOES AGE ADJUSTED CHARLSON COMORBIDITY SCORE STRONGLY PREDICT OUTCOME OF THE PATIENTS WITH FOLLICULAR LYMPHOMA TREATED WITH IMMUNOCHEMOTHERAPY?
Jelicic, J.
Todorovic, M.
Andjelic, B.
Sretenovic, A.
Antic, D.
Bila, J.
Stanisavljevic, D.
Djurasinovic, V.
Vukovic, V.
Smiljanic, M.
Mihaljevic, B.
HAEMATOLOGICA, 2015, 100 : 462 - 462
[8] FCGRIIIA RECEPTOR GENOTYPE DOES NOT INFLUENCE AN OUTCOME IN PATIENTS WITH FOLLICULAR LYMPHOMA TREATED WITH RISK-ADAPTED IMMUNOCHEMOTHERAPY
Prochazka, V.
Papajik, T.
Raida, L.
Kubova, Z.
Faber, E.
Indrak, K.
Jarosova, M.
Divoka, M.
Gazdova, J.
Sedova, Z.
Kucerova, L.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 174 - 175
[9] Results of mantle cell lymphoma treated with various immunochemotherapy regimens: A retrospective study
Enciso, Leonardo J.
Suarez, Martha L.
Arango, Marcos
REVISTA COLOMBIANA DE CANCEROLOGIA, 2015, 19 (02): : 71 - 80
[10] Prognostic Value of Tumor Mutational Burden in Follicular Lymphoma Patients Treated with Immunochemotherapy
Lafuente, Marta
Diez-Feijoo, Ramon
Fernandez-Rodriguez, Concepcion
Longaron, Raquel
Fernandez-Ibarrondo, Lierni
Garcia-Gisbert, Nieves
Garcia-Recio, Marta
Sanchez-Gonzalez, Blanca
Pinzon, Sergio
Gibert, Joan
Camacho, Laura
Colomo, Luis
Gutierrez, Antonio
Bellosillo, Beatriz
Salar, Antonio
BLOOD, 2023, 142

← 1 2 3 4 5 →